Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -12.45
- Piotroski Score 3.00
- Grade N/A
- Symbol (GBS)
- Company GBS Inc.
- Price $0.47
- Changes Percentage (-1.58%)
- Change -$0.01
- Day Low $0.45
- Day High $0.49
- Year High $2.89
GBS Inc. operates as a biosensor diagnostic technology company in the Asia-Pacific and North America. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. GBS Inc. has a research agreement with Johns Hopkins Bloomberg School of Public Health for the development of saliva-based diagnostic tests. The company was formerly known as Glucose Biosensor Systems (Greater China) Holdings, Inc. and changed its name to GBS Inc. in September 2019. The company was incorporated in 2016 and is headquartered in New York, New York. GBS Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 08/31/2022
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Buy
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.50
- Trailing P/E Ratio -0.94262948207171
- Forward P/E Ratio -0.94262948207171
- P/E Growth -0.94262948207171
- Net Income $-10,631,720
Income Statement
Quarterly
Annual
Latest News of GBS
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
The week in classical: Prom 31: West-Eastern Divan Orchestra/Barenboim; GBSR Duo - review
Renowned musician Daniel Barenboim led an emotional concert with his ensemble at the Royal Albert Hall, showcasing his enduring musical prowess despite frail health. The performance was a poignant tes...
By The Guardian | 1 month ago
